Bellevue Life Sciences Acquisition (BLAC) Stock Chart & Stock Price History $0.50 -0.03 (-5.45%) As of 08/20/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Bellevue Life Sciences Acquisition Stock Price Performance The Bellevue Life Sciences Acquisition (BLAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 95.36%, with a year-to-date return of -95.65%. In the past month, the stock has decreased 52.70%, reflecting recent market activity. As of the latest close, Bellevue Life Sciences Acquisition traded at $0.53 with a market cap of $2.14 million and volume of 145,907 shares. Receive BLAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.64%1 Month Performance-52.70%3 Month Performance-55.63%Year-To-Date Performance-95.65%1 Year Performance-95.36% BLAC Stock Chart for Thursday, August, 21, 2025 BLAC Chart by TradingView Bellevue Life Sciences Acquisition Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/20/2025$0.53$0.53+0.15%$0.56$0.51145,907 shs$2.14 million08/19/2025$0.53$0.53$0.54$0.5268,941 shs$2.14 million08/18/2025$0.53$0.53$0.54$0.5268,941 shs$2.14 million08/15/2025$0.56$0.56$0.59$0.56114,310 shs$2.27 million08/14/2025$0.60$0.56-7.09%$0.59$0.56114,310 shs$12.16 million08/13/2025$0.60$0.60$0.64$0.5977,807 shs$2.44 million08/12/2025$0.60$0.60$0.64$0.5977,807 shs$2.44 million08/11/2025$0.60$0.60$0.64$0.5977,807 shs$2.44 million08/08/2025$0.66$0.62-5.50%$0.65$0.60217,280 shs$2.50 million08/07/2025$0.66$0.66$0.67$0.62159,749 shs$2.65 million Get the Latest News and Ratings for BLAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$0.66$0.66$0.67$0.62159,749 shs$2.65 million08/05/2025$0.64$0.66+1.98%$0.67$0.62159,749 shs$2.65 million08/04/2025$0.64$0.64$0.73$0.62400,443 shs$2.60 million08/01/2025$0.87$0.69-20.44%$0.80$0.651.26 million shs$2.78 million07/31/2025$0.94$0.87-8.32%$0.97$0.836.94 million shs$3.50 million07/30/2025$0.94$0.94$1.04$0.91387,491 shs$3.81 million07/29/2025$0.98$0.94-3.72%$1.04$0.91387,491 shs$3.81 million07/28/2025$0.98$0.98$1.06$0.90756,392 shs$3.96 million07/25/2025$1.02$1.02$1.05$1.0274,052 shs$4.12 million07/24/2025$1.06$1.02-3.77%$1.05$1.0274,052 shs$4.12 million07/23/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million07/22/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million07/21/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million Related Companies LUCY Stock Chart CODX Stock Chart SINT Stock Chart ICU Stock Chart LFWD Stock Chart HSCS Stock Chart PAVM Stock Chart POAI Stock Chart SSKN Stock Chart STRR Stock Chart Receive BLAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BLAC) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access